insights_auto
Why is EDIT down ၂.၁၅%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
၂.၇၃ US$
arrow_downward
-၂.၁၅%(-၀.၀၆၀) 1D
၂.၈၇ US$
arrow_upward
+၅.၀၂% (+၀.၁၄)bedtimeAfter hours
Closed: အောက် ၆, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
၂.၈၅ US$
High
၂.၉၀ US$
Low
၂.၇၂ US$
Mkt. cap
၃၉.၃၇ ကုဋေ
Avg. vol.
၂.၉၁ သန်း
Volume
၂.၉၇ သန်း
52-wk high
၄.၅၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၇၄ US$
Beta
၂.၀၀
Shares outstanding
၁၅.၃၆ ကုဋေ
No. of employees
၈၇
Open
၂.၈၅ US$
High
၂.၉၀ US$
Low
၂.၇၂ US$
Mkt. cap
၃၉.၃၇ ကုဋေ
Avg. vol.
၂.၉၁ သန်း
Volume
၂.၉၇ သန်း
52-wk high
၄.၅၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၇၄ US$
Beta
၂.၀၀
Shares outstanding
၁၅.၃၆ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၃ နာရီ
Editas Medicine stock gains as Q2 revenue reaches USD 11.89 million
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc